A voluntary 2021 model and 2023 IRA expansion reduced mean quarterly insulin out-of-pocket spending by ~$106 overall, dropping the share paying >$35 per 30-day supply from 62.1% to 0.11%. Insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results